Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation

Ichelle van Roessel, Susan Prockop, Elizabeth Klein, Farid Boulad, Andromachi Scaradavou, Barbara Spitzer, Andrew Kung, Kevin Curran, Richard J. O'Reilly, Nancy A. Kernan, Maria Cancio, Jaap Jan Boelens

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

16 Citaten (Scopus)

Samenvatting

Background: An association between early CD4+ T cell immune reconstitution (CD4+ IR) and survival after T-replete allogeneic hematopoietic cell transplantation (HCT) has been previously reported. Here we report validation of this relationship in a separate cohort that included recipients of ex vivo T-cell-depleted (TCD) HCT. We studied the relationship between CD4+ IR and clinical outcomes. Methods: A retrospective analysis of children/young adults receiving their first allogeneic HCT for any indication between January 2008 and December 2017 was performed. We related early CD4+ IR (defined as achieving >50 CD4+ T cells/µL on two consecutive measures within 100 days of HCT) to overall survival (OS), relapse, non-relapse mortality (NRM), event-free survival (EFS) and acute graft-versus-host disease (aGVHD). Fine and Gray competing risk models and Cox proportional hazard models were used. Results: In this analysis, 315 patients with a median age of 10.4 years (interquartile range 5.0–16.5 years) were included. The cumulative incidence of CD4+ IR at 100 days was 66.7% in the entire cohort, 54.7% in TCD (N = 208, hazard ratio [HR] 0.47, P < 0.001), 90.0% in uCB (N = 40) and 89.6% in T-replete (N = 47) HCT recipients. In multi-variate analyses, not achieving early CD4+ IR was a predictor of inferior OS (HR 2.35, 95% confidence interval [CI] 1.46–3.79, P < 0.001) and EFS (HR 1.80, 95% CI 1.20–2.69, P = 0.004) and increased NRM (HR 6.58, 95% CI 2.82–15.38, P < 0.001). No impact of CD4+ IR on relapse or aGVHD was found. Within the TCD group, similar associations were observed. Conclusion: In this HCT cohort, including recipients of TCD HCT, we confirmed that early CD4+ IR was an excellent predictor of outcomes. Finding strategies to predict or improve CD4+ IR may influence outcomes.

Originele taal-2Engels
Pagina's (van-tot)503-510
Aantal pagina's8
TijdschriftCytotherapy
Volume22
Nummer van het tijdschrift9
DOI's
StatusGepubliceerd - sep. 2020

Vingerafdruk

Duik in de onderzoeksthema's van 'Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation'. Samen vormen ze een unieke vingerafdruk.

Citeer dit